Pfizer to test updated shot against Delta strain in August

Wednesday, 28. July 2021 13:52

Pfizer Inc. and BioNTech SE announced on Wednesday that they intend to evaluate the immune response and safety of their coronavirus vaccine "specifically designed to target the Delta variant" next month.

In the meantime, the companies will discuss the potential third dose booster of their current shot with regulatory agencies, with the Emergency Use Authorization submission expected also in August.

"We continue to believe it is likely that a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection," Pfizer's officials said during a conference call following the release of the company's latest earnings report.

Related Links: BioNTech SEPfizer Inc.
Breaking the News / MS